TOMORROW: pediaTric use Of Macitentan tO delay disease pRogRessiOn in PAH Worldwide A multicenter, open-label, randomized, event-driven study to assess efficacy, safety and pharmacokinetics of macitentan

Administered By

Awarded By

Contributors

Start/End

  • August 17, 2017 - June 30, 2024